Alkermes. Every tracked FinTwit mention of $ALKS, newest first. 6 mentions since the first on Jul 21, 2025. See the price chart.
February 2026 · 1 mention
Feb 25
Adam Feuerstein ✡️ — $ALKS CEO Richard Pops is retiring!
https://t.co/fv1YjIhqJX↗
November 2025 · 1 mention
Nov 19
Adam Feuerstein ✡️ — $ALKS increases bid for $AVDL to $22.50 per share, topping Lundbeck.↗
October 2025 · 1 mention
Oct 22
Adam Feuerstein ✡️ — Alkermes $ALKS buying Avadel $AVDL for up to $20 per share. Deal value $2.1B↗
September 2025 · 1 mention
Sep 8
Adam Feuerstein ✡️ — $ALKS $TAK orexin data presentations from the sleep meeting in Singapore.
Alkermes, Takeda show encouraging data on narcolepsy drugs https://t.co/TJtEk9EgeB via @elaineywchen↗
July 2025 · 2 mentions
Jul 22
Adam Feuerstein ✡️ — Drugmakers are racing to help patients stay awake — and could also make billions
A great read from my colleague @elaineywchen reporting on the development of orexin inhibitors $AL…↗
Jul 21
Adam Feuerstein ✡️ — Alkermes $ALKS drug helped narcolepsy patients stay awake in Phase 2 trial https://t.co/DpzjXfK3n8
More orexin results but no numbers for now. via @elaineywchen↗